StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Baird Defends Cardinal Health (CAH): 'Market fears played out, buyers on weakness'
April 23, 2024 6:21 AM
Baird analyst Eric Coldwell reiterated an Outperform rating and $134.00 price target on Cardinal Health (NYSE: CAH).The analyst comments "Market ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Cardinal Health (CAH) shares down after losing OptumRx contracts
April 22, 2024 4:00 PM
Cardinal Health (CAH) options active on 7K contracts as share price down 4%
April 22, 2024 3:11 PM
TD Cowen Reiterates Hold Rating on Cardinal Health (CAH)
April 22, 2024 11:47 AM
Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
April 22, 2024 8:35 AM
Drug distributor Cardinal Health to lose OptumRx contracts
April 22, 2024 7:29 AM
Form 8-K CARDINAL HEALTH INC For: Apr 22
April 22, 2024 6:49 AM
Cardinal Health (CAH) Reaffirms 2024 Guidance
April 22, 2024 6:46 AM
Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts
April 22, 2024 6:45 AM
